UC Irvine Medical Center — Orange, California

Public research footprint of UC Irvine Medical Center, compiled from the ClinicalTrials.gov public registry.

127

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Metastatic Castration-resistant Prostate Cancer (mCRPC) · Breast Neoplasms · Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction… · Untreated, Unresectable, or Metastatic Colorectal Cancer

Recently updated registry entries

NCT06952504 — A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… (Recruiting)
NCT05291091 — Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON) (Active Not Recruiting)
NCT06066580 — Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy (Enrolling By Invitation)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at UC Irvine Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.